9KW-12560-95232
4 vaccinations
5 coded responses
46 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 778 / TX
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Moderna
- 2021-01-13
-
2021-01-15
Survey response — days 1–6 daily, dose 1MedDRA: Body temperature increased, Injection site pain, Malaise, Pain in extremity — Feeling: Good · Site: Pain · Muscle or body achesFree text: Yesterday was really rough compared to today. I had severe arm pain, 1-1.5 degree higher temperature, and malaise. These were resolved when I woke up this morning, however I still have slight muscle/arm pain at injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: Pain · Muscle or body achesFree text: Very mild muscle pain at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-19
- 2021-01-22
- 2021-01-27
- 2021-02-03
- 2021-02-10
-
2021-02-12
Dose 2 — Moderna
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-05-14
- 2021-08-13
-
2021-10-25
Dose 3 — Moderna
- 2021-10-25
-
2021-10-26
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-08
-
2021-11-16
Survey response — day 21, dose 3MedDRA: Cough, Dysgeusia, Paranasal sinus discomfort, Paranasal sinus hypersecretion, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: FairFree text: Upper respiratory infection began about 5 days ago. Symptoms included sinus pressure & drainage, cough, metallic taste, however the taste could be partially explained by guaifenesin. Have had 2 negative Covid rapid tests.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-22
Survey response — day 28, dose 3MedDRA: Cough, Dysgeusia, Sinus congestion — Feeling: GoodFree text: Metallic taste has continued to at bothersome level as sinus congestion and cough have improved.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-29
- 2021-12-06
- 2022-01-24
- 2022-04-25
-
2022-06-03
Dose 4 — Moderna
- 2022-06-21
- 2022-06-24
- 2022-07-01
- 2022-07-08
- 2022-07-15
-
2022-09-02
Survey response — 3 months, dose 4MedDRA: Lethargy, Nasopharyngitis, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid positive 8/27/22 by rapid test. Mild cold symptoms with mild lethargy. No fever.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-02
- 2023-06-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2021-10-25 | Moderna | No |
| 4 | 2022-06-03 | Moderna | No |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Yesterday was really rough compared to today. I had severe arm pain, 1-1.5 degree higher temperature, and malaise. These were resolved when I woke up this morning, however I still have slight muscle/arm pain at injection site.
Systemic reaction (other): Very mild muscle pain at injection site
Release 10 — day 21, dose 3
Symptoms: Upper respiratory infection began about 5 days ago. Symptoms included sinus pressure & drainage, cough, metallic taste, however the taste could be partially explained by guaifenesin. Have had 2 negative Covid rapid tests.
Release 10 — day 28, dose 3
Symptoms: Metallic taste has continued to at bothersome level as sinus congestion and cough have improved.
Release 12 — 3 months, dose 4
Symptoms: Covid positive 8/27/22 by rapid test. Mild cold symptoms with mild lethargy. No fever.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dysgeusia | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Body temperature increased | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Malaise | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release